Arkansas State University
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.astate.edu
UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
- Conditions
- Multiple Myeloma
- Interventions
- Device: myPRSDrug: Induction 1 - MEL-10+CFZ-TD-PACEDrug: First Transplant - MEL-80+CFZ-TD-PACE + PBSC (biologic)Drug: Inter-Therapy - MEL-20+CFZ-TD-PACE (75%)Drug: Second Transplant - MEL-80+CFZ-TD-PACE + PBSC (biologic)Drug: Consolidation - CFZ-TD-PACEDrug: Maintenance - CFZ-R(T)-D
- First Posted Date
- 2014-05-01
- Last Posted Date
- 2021-06-22
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 20
- Registration Number
- NCT02128230
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib
- Conditions
- Multiple Myeloma
- Interventions
- Drug: Vermurafenib
- First Posted Date
- 2014-04-15
- Last Posted Date
- 2014-08-27
- Lead Sponsor
- University of Arkansas
- Registration Number
- NCT02115035
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
The Effects of ProFoveate on Reducing Self-Stimulating Behaviors
- Conditions
- Autism Spectrum DisordersNormal HearingExhibit Self- Stimulating or Ritualistic BehaviorsNormal Intelligence
- Interventions
- Device: ProFoveate
- First Posted Date
- 2014-03-14
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 4
- Registration Number
- NCT02088047
- Locations
- 🇺🇸
University of Arkansas at Little Rock Speech and Hearing Clinic, Little Rock, Arkansas, United States
MR Imaging Biomarkers of Disease Response to ECT (Electroconvulsive Therapy) in Depression
- Conditions
- Depression
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2016-02-03
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 12
- Registration Number
- NCT02044289
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
- Conditions
- Multiple Myeloma
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2015-03-03
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 100
- Registration Number
- NCT02035189
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little rock, Arkansas, United States
Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence
- Conditions
- Methamphetamine Dependence
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2017-08-22
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 19
- Registration Number
- NCT02034201
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- Conditions
- Refractory AscitesHepatic HydrothoraxCirrhosisHepatic Encephalopathy
- Interventions
- Other: Oral glutamine challengeOther: Psychometric Tests
- First Posted Date
- 2014-01-03
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 3
- Registration Number
- NCT02026609
- Locations
- 🇨🇦
University of Montreal, Montreal, Quebec, Canada
🇨🇭University Hospitals of Geneva, Geneva, Switzerland
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema
- Conditions
- LymphedemaPost Mastectomy
- Interventions
- Procedure: Lymphaticovenous Micro-Anastomosis
- First Posted Date
- 2013-12-25
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 2
- Registration Number
- NCT02020837
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
- First Posted Date
- 2013-12-16
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 14
- Registration Number
- NCT02012608
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Etiology and Early Diagnosis of Neurodevelopmental Disorders
- Conditions
- Neurodevelopmental Disorders
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 576
- Registration Number
- NCT02003170
- Locations
- 🇺🇸
Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States